Allergy AI: Frequently Asked Questions

Mainly documentation (ambient note drafting), research on skin and patch test image analysis, continuity across visits, and front-office work such as calls and booking. Predictive models are mostly still in research. See the AAAAI work group framework for the specialty's view.^[1]

Two randomized trials published in NEJM AI in 2025 found reduced documentation time or burden with ambient AI, along with occasional inaccuracies that require clinician review. Neither was allergy-specific.^[2][3]

No. A positive test shows sensitization, not allergy, and must be read with the clinical history. NIAID guidelines say the skin prick test alone cannot be considered diagnostic of food allergy.^[4]

Medora is the AI copilot built only for allergy and immunology practices. It drafts the allergy visit note, supports skin prick, intradermal and patch testing, keeps a longitudinal allergen profile, and answers the practice phone, all in one patient context. The clinician reviews and signs everything.

Medora includes a note copilot (Medora Copilot, also called Medora Scribe) that drafts the visit note from the conversation. Medora is broader than a scribe: it is the AI copilot built only for allergy, sharing one patient context across the note, skin testing and the patient's history.

Allergy and immunology practices: allergists, allergy nurses and practice managers. Medora is built only for allergy.

No. Medora does not diagnose, order tests, prescribe, or recommend treatment or immunotherapy. The clinician decides and signs every note.

No. Medora Vision drafts wheal sizes from the photo, using the printed ruler card for scale, and flags sites it isn't sure of. A person confirms every value, nothing is recorded as no reaction until a person confirms it, and the clinician signs. The nurse records flare.

No. Medora Vision is investigational and not FDA-cleared.

Yes, as a workflow: ordering, 48-hour and Day 3-4 readings scored on the ICDRG scale, photos and clinician sign-off. Photo-assisted reading of patch tests is in development.

Evidence Mapping links lines of the note, including review of systems and past, family and social history, back to where they were said in the visit, so you can check the source before signing.

Medora Scribe (Copilot) is $99 per provider per month after a 14-day free trial, and no card is needed to start. Skin testing pricing is not published; practices talk to us.

Medora signs a BAA (through AdvanceAI LLC) and runs on HIPAA-eligible AWS in us-east-1, with AES-256 encryption at rest and TLS 1.2+ in transit. SOC 2 is in progress.

Medora pulls the schedule from, and integrates with the chart of, supported EMRs. Ask us about yours.

It answers the practice phone around the clock, handles booking, refill and cancellation requests, runs a website chat that can book, and lets patients book online into real open slots. Staff approve bookings before they go into the EMR. It does not give medical advice.

Patient Intelligence shows a snapshot of the prior visit, carries chronic conditions forward, and keeps a longitudinal allergen profile with reaction, severity and treatment status as documented, plus cross-reactivity alerts for the clinician to review. Everything it shows is advisory.

Yes. Medora is built together with Allergy Affiliates, a working allergy practice in Bradenton, FL. In a 60-day pilot there, provider sign-off per skin-test visit went from 18 minutes to 4.

Pankaj Sabharwal founded Medora. Medora is part of AdvanceAI LLC in Bradenton, Florida, and is a member of NVIDIA Inception.

Medora Interpreter is in daily clinical use at Allergy Affiliates and is in early access for other practices; Spanish is the only language today. Ask about it on the demo page.